Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Posted on by Neuroscientists

Prof. Dr. Hongrui Meng | Neurodegenerative disease | Excellence in Research Award

Prof. Dr. Hongrui Meng,  Institute of Neuroscience, Soochow University, China.

Dr. Hongrui Meng is a highly accomplished neuroscientist whose academic path began with a Ph.D. in Behavioural Neuroscience from Hamamatsu University School of Medicine in Japan. He later conducted postdoctoral research in molecular neurobiology and human genetics at Juntendo University, Tokyo. Currently a professor at the Institute of Neuroscience, Soochow University, Dr. Meng leads a research team dedicated to uncovering the molecular and mitochondrial mechanisms underlying Parkinson’s disease and ALS. His work spans high-impact research projects funded by JSPS, NSFC, and other prestigious bodies. In addition to numerous scientific publications, he has contributed to diagnostic innovation through patented miRNA detection methods. His influence extends beyond academia through translational applications such as wearable technologies for Parkinson’s symptom monitoring.

Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hongrui Meng began his distinguished academic journey in the field of neuroscience by earning his Ph.D. in Behavioural Neuroscience from the prestigious Hamamatsu University School of Medicine in Japan. His early education and training laid a strong foundation in experimental neuroscience, with a focus on the behavioral manifestations of neurodegenerative conditions. These formative years not only sharpened his scientific curiosity but also equipped him with the cross-disciplinary expertise to address complex neurological questions.

🧠 Professional Endeavors

Following his doctoral studies, Dr. Meng advanced his specialization through postdoctoral training in molecular neurobiology and human genetics at Juntendo University in Tokyo. There, he immersed himself in high-level research focusing on the genetic underpinnings of neurological disorders. His competence and dedication soon earned him a faculty appointment as an Assistant Professor in the Department of Research for Neurodegenerative Diseases and Dementia. His professional arc reached a significant milestone in 2020 when he was promoted to Full Professor and moved to the Institute of Neuroscience at Soochow University, where he now leads the Laboratory of Molecular Neurology.

🧬 Contributions and Research Focus

Dr. Meng’s scientific contributions center on the molecular mechanisms of Parkinson’s disease and amyotrophic lateral sclerosis (ALS). His research bridges mitochondrial dysfunction, alpha-synuclein aggregation, and neurodegeneration. He has completed pivotal studies supported by the Japan Society for the Promotion of Science and the Takeda Pharmaceutical Foundation, delving into the role of CHCHD2 gene mutations and mitochondrial pathways. His ongoing projects funded by the National Natural Science Foundation of China (NSFC) explore mitochondrial unfolded protein responses (mtUPR), while another innovative project in Suzhou focuses on wearable technology for monitoring Parkinson’s disease symptoms—demonstrating his commitment to translational and patient-centered neuroscience.

🔬 Innovation and Scientific Output

A notable innovator, Dr. Meng has made strides in molecular diagnostic technologies. His work has led to the development of high-throughput RT-qPCR-based methods for detecting primary and precursor miRNAs, contributing to enhanced genetic analysis of neurodegenerative disorders. He holds a patent granted in South Africa and another under process in China, underscoring his role at the intersection of research and technology. Furthermore, his publications in highly regarded journals like Current Issues in Molecular Biology and Cell Communication and Signaling reflect a consistent record of impactful findings that inform both fundamental neuroscience and clinical approaches.

🏅 Accolades and Recognition

Dr. Meng’s ascent in the academic community has been marked by numerous grants, including multiple from the JSPS and NSFC, attesting to the trust placed in his research vision by top funding bodies. While a formal list of awards may be under-documented, his rapid progression from postdoctoral fellow to professor and research team leader in less than a decade speaks volumes about his recognition among peers and institutional leadership. His leadership in multi-disciplinary and international collaborations is an implicit accolade of his scientific reliability and visionary perspective.

🌍 Impact and Influence

Through his groundbreaking work on mitochondrial mechanisms and neurodegeneration, Dr. Meng is helping to reshape current understanding of Parkinson’s disease pathophysiology. His investigations into alpha-synucleinopathy and microglial disruption have provided fresh insights into cellular degeneration and neuroimmune interactions. Beyond academia, his involvement in developing wearable diagnostic tools highlights his drive to impact patient lives directly. As a consultant on neuroprotective treatments such as PD-018/19, he bridges the academic and pharmaceutical worlds to accelerate therapeutic discovery.

🔮 Legacy and Future Contributions

Looking forward, Dr. Meng is poised to be a leading figure in neurogenetic diagnostics and therapeutic innovation. His laboratory at Soochow University serves as an incubator for future discoveries in neurodegenerative disease mechanisms, and his continued work in mitochondrial research promises to inform emerging therapies. With a growing publication record, international patents, and a robust research pipeline, Dr. Meng’s legacy will be one of bridging basic neuroscience with clinical application—paving the way for novel interventions and a better understanding of brain disorders in the molecular era.

Publication

 

  • Title: Dicer Is Involved in Cytotoxicity and Motor Impairment Induced by TBPH Deficiency
    Authors: Xiang Long, Yijie Wang, Hongrui Meng
    Year: 2025

 

  • Title: Transcriptomic analysis of lipid metabolism genes in Alzheimer’s disease: highlighting pathological outcomes and compartmentalized immune status
    Authors: Sun Y., Zhang Y., Jiang M., Long X., Miao Y., Du H., Zhang T., Meng H., Ma X.
    Year: 2024

 

  • Title: CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis
    Authors: Aya Ikeda, Hongrui Meng, Daisuke Taniguchi, Muneyo Mio, Manabu Funayama, Kenya Nishioka, Mari Yoshida, Yuanzhe Li, Hiroyo Yoshino, Tsuyoshi Inoshita et al.
    Year: 2024

 

  • Title: TDP-43 mutations-induced defects in miRNA biogenesis and cytotoxicity by differentially obstructing Dicer activity in Drosophila and in vitro
    Authors: Xiang Long, Mengni Jiang, Yongzhen Miao, Huanhuan Du, Ting Zhang, Zhuoya Ma, Jiao Li, Chunfeng Liu, Hongrui Meng
    Year: 2024

 

  • Title: A Simple Technique to Assay Locomotor Activity in Drosophila
    Authors: Long X., Du H., Jiang M., Meng H.
    Year: 2023

 

  • Title: Functional MHCI deficiency induces ADHD-like symptoms with increased dopamine D1 receptor expression
    Authors: Meng H.-R., Suenaga T., Edamura M., Nakahara D., Murakami G., Fukuda A., Ishida Y.
    Year: 2021

 

  • Title: Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease
    Authors: Imai Y., Hattori N., Inoshita T., Shiba-Fukushima K., Meng H., Hara K.Y., Sawamura N.
    Year: 2019

 

  • Title: Mutations in CHCHD2 cause α-synuclein aggregation
    Authors: Ikeda A., Nishioka K., Takanashi M., Li Y., Mori A., Okuzumi A., Izawa N., Ishikawa K.-I., Funayama M., Imai Y. et al.
    Year: 2019

 

  • Title: Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling
    Authors: Mori A., Hatano T., Koinuma T., Kubo S.-I., Spratt S., Yamashita C., Okuzumi A., Imai Y., Hattori N., Inoshita T. et al.
    Year: 2019

 

  • Title: Twin CHCH proteins, CHCHD2, and CHCHD10: Key molecules of Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia
    Authors: Imai Y., Hattori N., Meng H., Shiba-Fukushima K.
    Year: 2019

 

🧾 Conclusion

Dr. Hongrui Meng’s career reflects a dynamic blend of academic excellence, molecular research innovation, and translational neuroscience. His scientific endeavors have not only enriched the understanding of neurodegenerative diseases but have also paved the way for novel diagnostic and therapeutic strategies. With a growing portfolio of impactful research, patents, and leadership in neurobiology, Dr. Meng stands out as a driving force in the global fight against neurological disorders. His work promises continued contributions to neuroscience with lasting influence on both scientific knowledge and patient care.

 

EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Posted on by Neuroscientists

Assist. Prof. Dr. EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Assist. Prof. Dr.  EMRE MISIR, Baskent University, Turkey.

Dr. Emre MISIR is a distinguished psychiatrist and neuroscience researcher, whose academic journey began at Adnan Menderes University and led to specialization in psychiatry at Dokuz Eylül University. His professional career includes serving as a Specialist Physician at Yozgat City Hospital before transitioning to an academic role at Başkent University Faculty of Medicine. Currently, he is pursuing a Ph.D. in Interdisciplinary Neuroscience at Ankara University, focusing on Theory of Mind in Obsessive-Compulsive Disorder (OCD). His outstanding exam scores, professional memberships, and active research contributions underscore his dedication to advancing psychiatry.

Profile

Orcid

Early Academic Pursuits 🎓

Born on July 16, 1989, in Şahinbey, Gaziantep, Turkey, Dr. Emre MISIR embarked on an academic journey rooted in a passion for medicine and mental health. He completed his medical education at Adnan Menderes University between 2006 and 2012, where his keen interest in the complexities of the human mind began to take shape. His dedication and academic excellence led him to pursue a specialization in psychiatry at Dokuz Eylül University Faculty of Medicine, where he trained extensively from 2012 to 2017.

Professional Endeavors 🏥

Following his specialization, Dr. MISIR served as a Specialist Physician at Yozgat City Hospital from 2017 to 2020, providing essential mental health care to diverse patient populations. In July 2020, he transitioned to Başkent University Faculty of Medicine, where he continued his professional practice before taking on a more academic role. By April 2020, his expertise and commitment to education earned him a Lecturer position at Başkent University, where he has been actively involved in mentoring young psychiatrists and medical students.

Contributions and Research Focus 🔬

With a profound interest in the intersection of psychiatry and neuroscience, Dr. MISIR has dedicated his research to understanding complex cognitive and psychological disorders. Currently pursuing a doctoral program in Interdisciplinary Neuroscience at Ankara University, his research explores the intricate mechanisms underlying obsessive-compulsive disorder (OCD). His thesis, titled “Theory of Mind in Patients with Obsessive-Compulsive Disorder: Relationship with Cognitive Functions, Overvalued Ideas, Insight, Schizotypal Personality Traits, and Other Clinical Characteristics,” under the supervision of Prof. Dr. Berna Binnur Kıvırcık Akdede, sheds light on the cognitive and neurobiological factors influencing psychiatric conditions.

Accolades and Recognition 🏅

Dr. MISIR’s commitment to academic excellence is reflected in his outstanding achievements in competitive examinations. His remarkable performance in the TUS Clinical Exam (Fall 2012) with a rank of 101, and his high ALES Numerical score of 88.58 demonstrate his academic rigor. Additionally, his proficiency in English, certified by a YÖKDİL score of 88.75, further amplifies his ability to contribute to international research and collaboration in psychiatry and neuroscience.

Impact and Influence 🌍

Beyond clinical practice and academia, Dr. MISIR is an active member of key professional organizations, including the Turkish Psychiatric Association, the Cognitive Behavioral Psychotherapy Association, and the Clinical Neuropsychopharmacology Association, where he serves as the Treasurer. His contributions to these organizations reflect his dedication to advancing psychiatric research and improving mental health treatments in Turkey and beyond. Through his engagement in professional networks, he has been instrumental in fostering interdisciplinary collaboration and promoting evidence-based psychiatric practices.

Legacy and Future Contributions 🚀

As a psychiatrist, researcher, and educator, Dr. MISIR continues to push the boundaries of neuroscience and psychiatric research. His work not only enhances the understanding of cognitive disorders but also paves the way for more effective diagnostic and therapeutic approaches. With his ongoing doctoral research and contributions to academic literature, he aspires to shape the future of psychiatric treatment, integrating neurobiological insights with clinical practice. His unwavering dedication to mental health and neuroscience ensures that his influence will extend beyond his current academic and clinical roles, leaving a lasting impact on the field.

Publication

  • Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder

    • Authors: Emre Mısır, Raşit Tükel, Berna Binnur Akdede, Emre Bora

    • Year: 2025

 

  • Validity and Reliability Study of the Turkish Form of the 4th Version of the Mental Illness: Clinicians’ Attitudes (MICA) Scale

    • Authors: Emre Mısır, Yasemin Hosgören Alıcı, Zeynep Bozkurt, Hüseyin Batuhan Elhan

    • Year: 2024

 

  • Functional connectivity in rumination: a systematic review of magnetic resonance imaging studies

    • Authors: Emre Mısır, Yasemin Hoşgören Alıcı, Orhan Murat Kocak

    • Year: 2023

 

  • Synaptic dysfunction in schizophrenia

    • Authors: Emre Mısır, Güvem Gümüş Akay

    • Year: 2023

 

  • The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis

    • Authors: Emre Misir, Mutlu Muhammed Ozbek, Eren Halac, Serkan Turan, Gokce Elif Alkas, Remzi Ogulcan Ciray, Cagatay Ermis

    • Year: 2022

 

  • DSM-5 Anksiyöz Distres Değerlendirme Ölçeği Türkçe Formunun Major Depresif Bozukluk için Geçerlilik ve Güvenilirlik Çalışması

    • Authors: Emre Mısır

    • Year: 2020

 

  • Reliability and validity of the Turkish Version of DSM-5 Anxious Distress Rating Scale for major depressive disorder

    • Authors: Misir, Emre; Hacimusalar, Yunus

    • Year: 2020

 

  • THE BRIEF RESIDENT WELLNESS PROFILE: VALIDITY AND RELIABILITY OF TURKISH VERSION

    • Authors: Misir, Gamze Akyol; Balik, Gurcan; Misir, Emre; Kartal, Mehtap

    • Year: 2020

 

  • The concept of schizotypy and schizotypal personality disorder

    • Authors: Misir, Emre; Alptekin, Koksal

    • Year: 2020

 

Conclusion 🌟

Dr. MISIR’s career embodies a commitment to merging clinical expertise with neuroscience research to enhance the understanding and treatment of psychiatric disorders. His contributions to academia, professional organizations, and clinical practice solidify his role as an influential figure in modern psychiatry. As he continues to explore the intricate mechanisms of mental health, his work promises to shape the future of psychiatric care and inspire the next generation of researchers and clinicians. His journey is one of excellence, innovation, and unwavering dedication to mental health and neuroscience.

Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Posted on by Neuroscientists

Dr. Kiran Solingapuram Sai | Neuroimaging | Best Researcher Award

Dr. Kiran Solingapuram Sai, Wake Forest School of Medicine, United States.

Dr. Kiran K. Solingapuram Sai, PhD, is an Associate Professor with tenure in the Department of Radiology at Wake Forest School of Medicine. He holds a Ph.D. in Organic Chemistry from Northern Illinois University and has extensive research experience in radiopharmaceutical chemistry. His postdoctoral training at Washington University’s Mallinckrodt Institute of Radiology focused on radiotracer development.

Profile

Orcid

 

✨ Early Academic Pursuits

Dr. Kiran K. Solingapuram Sai embarked on his academic journey with a strong foundation in chemistry, earning a Bachelor of Science degree in Chemistry, Biochemistry, and Microbiology from Osmania University, Hyderabad, India, in 2001. His passion for organic chemistry led him to pursue a Master of Science in the same field at Osmania University, where he honed his expertise in chemical synthesis and molecular interactions. Determined to explore the depths of organic chemistry, he pursued his Ph.D. at Northern Illinois University, DeKalb, IL, under the mentorship of Dr. Douglas A. Klumpp. During this period, his research focused on synthetic methodologies and organic reaction mechanisms, paving the way for his future contributions to medicinal and radiopharmaceutical chemistry.

🌐 Professional Endeavors

Dr. Sai’s professional journey commenced with a prestigious postdoctoral research associate position at the Mallinckrodt Institute of Radiology at Washington University in St. Louis, MO, where he worked under the guidance of Dr. Robert H. Mach. During his tenure from 2010 to 2013, he delved into the complexities of radiochemistry, developing novel radiotracers and exploring their applications in medical imaging. This experience laid the groundwork for his career in radiopharmaceutical sciences. In 2014, he joined Wake Forest School of Medicine as a Research Instructor and Chief Radiochemist, marking the beginning of his significant contributions to translational imaging and radiopharmaceutical production.

⚛️ Contributions and Research Focus

At Wake Forest School of Medicine, Dr. Sai played a pivotal role in the Department of Radiology and the Clinical Translational Science Institute (CTSI). He specialized in managing clinical and research-based radiopharmaceutical production at the Wake Forest PET Research Center. As a cyclotron manager and coordinator, he oversaw the synthesis and quality control of radiotracers essential for PET imaging. His expertise extended to the development and implementation of cGMP-approved protocols for C-11 and F-18 radiopharmaceutical production, ensuring the highest standards of safety and efficacy. His research focuses on advancing PET imaging techniques, exploring new radiotracers for diagnostic and therapeutic applications, and improving imaging biomarker development.

🏆 Accolades and Recognition

Dr. Sai’s dedication to radiochemistry and molecular imaging has earned him recognition in the scientific community. His work has been instrumental in developing radiopharmaceuticals for neurological and oncological imaging, contributing significantly to early disease detection and targeted therapy. His contributions have been acknowledged through numerous research grants, collaborative projects, and publications in high-impact scientific journals. His commitment to excellence and innovation has positioned him as a leading figure in the field of radiopharmaceutical sciences.

🔬 Impact and Influence

Beyond his research and technical expertise, Dr. Sai has mentored budding scientists and researchers in the field of radiochemistry and imaging sciences. His guidance has helped shape the next generation of radiopharmaceutical experts, fostering a culture of innovation and scientific curiosity. His role in translational imaging programs has bridged the gap between basic research and clinical applications, directly impacting patient care by improving diagnostic imaging techniques.

💡 Legacy and Future Contributions

Dr. Sai’s work continues to inspire advancements in molecular imaging and radiopharmaceutical development. As an Associate Professor with tenure at Wake Forest School of Medicine, he remains dedicated to pushing the boundaries of radiochemistry, developing cutting-edge imaging agents, and enhancing the precision of diagnostic medicine. His legacy in the field is defined by his unwavering commitment to scientific discovery, translational research, and the continuous pursuit of excellence in radiopharmaceutical sciences.Dr. Kiran K. Solingapuram Sai’s contributions to the field of radiopharmaceutical chemistry stand as a testament to his dedication, innovation, and impact on medical imaging and healthcare. His journey from a passionate chemistry student to a distinguished professor and researcher highlights the transformative power of science in shaping the future of medicine.

 

Publication

  1. Radiation-induced brain injury in non-human primates: A dual tracer PET study with [11C]MPC-6827 and [11C]PiB

    • Authors: Naresh Damuka, George W. Schaaf, Mack Miller, Caleb Bradley, Bhuvanachandra Bhoopal, Ivan Krizan, Krishna K. Gollapelli, Christopher T. Whitlow, J. Mark Cline, Kiran K. Solingapuram Sai
    • Year: 2025

 

  1. The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer

    • Authors: Hilal A. Rather, Sameh Almousa, Ashish Kumar, Mitu Sharma, Isabel Pennington, Susy Kim, Yixin Su, Yangen He, Abdollah R. Ghara, Kiran Kumar Solingapuram Sai et al.
    • Year: 2023

 

  1. Development and Optimization of 11C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process

    • Authors: Paul Josef Myburgh, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents

    • Authors: Avinash H. Bansode, Bhuvanachandra Bhoopal, Krishna Kumar Gollapelli, Naresh Damuka, Ivan Krizan, Mack Miller, Suzanne Craft, Akiva Mintz, Kiran Kumar Solingapuram Sai
    • Year: 2023

 

  1. PET Imaging of [11C]MPC-6827, a Microtubule-Based Radiotracer in Non-Human Primate Brains

    • Authors: Naresh Damuka, Paul W. Czoty, Ashley T. Davis, Michael Nader, Susan H. Nader, Suzanne Craft, Shannon L. Macauley, Lindsey K. Galbo Thomma, Phillip M. Epperly, Christopher T. Whitlow et al.
    • Year: 2020

 

  1. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists

    • Authors: Nagaraju Bashetti, J.V. Shanmukha Kumar, Naresh Varma Seelam, B. Prasanna, Akiva Mintz, Naresh Damuka, Sriram Devanathan, Kiran Kumar Solingapuram Sai
    • Year: 2019

 

Conclusion

Dr. Kiran K. Solingapuram Sai has established himself as a leading expert in radiopharmaceutical sciences, contributing significantly to translational imaging research. His work in PET radiopharmaceutical production and quality assurance underscores his role in advancing medical imaging techniques. His academic and research contributions make him a valuable asset in the field of radiology and molecular imaging.

John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Posted on by Neuroscientists

Dr. John Vincent Sanchez Orti | Biomarkers in Neurocognition | Young Scientist Award

Dr. Joan Vicent Sánchez Ortí, Health research institute,  Spain.

Joan Vicent Sánchez Ortí is a Clinical Psychologist and Neuropsychologist currently working as a Research Technician at the Instituto de Investigación Sanitaria – INCLIVA. He is also a predoctoral researcher affiliated with CIBERSAM (Group 24, Universitat de València). His academic background includes a Bachelor’s degree in Psychology (2016), a Master’s in General Health Psychology (2019), and a Master’s in Basic and Applied Neurosciences (2021), all from Universitat de València. He is currently pursuing a Ph.D. in Medicine.

Profile

Google Scholar

Orcid

🧠 A Passion for Understanding the Mind

Joan Vicent Sánchez Ortí was born on August 6, 1994, with an innate curiosity about the complexities of human cognition. From an early age, he displayed a deep interest in psychology and neuroscience, which led him to pursue an academic path dedicated to unraveling the mysteries of the brain. His journey began at the Universitat de València, where he obtained his degree in Psychology in 2016. Motivated by his growing fascination with neuropsychology, he continued his studies, earning a Master’s in General Health Psychology in 2019 and a Master’s in Basic and Applied Neurosciences in 2021. His dedication to advancing medical science led him to enroll in an official Doctorate Program in Medicine at the same institution.

🏥 Bridging Psychology and Neuroscience in Professional Practice

Currently serving as a Neuropsychologist and Research Technician at the Health Research Institute (INCLIVA) in Spain, Joan Vicent plays a vital role in understanding cognitive impairments associated with severe mental disorders. His affiliation with the Biomedical Research Center in Mental Health Network (CIBERSAM) – Group 24 at the Universitat de València has allowed him to contribute significantly to groundbreaking studies. His expertise lies in assessing neurocognitive deficits, biomarkers, and epigenetic factors, aiming to enhance the diagnosis and treatment of psychiatric and neurological conditions.

🔬 Advancing Research in Neurocognitive Deficits and Mental Health

Joan Vicent’s research delves into the intricate connections between brain function, cognition, and mental health. His studies focus on identifying early biomarkers of cognitive decline, exploring epigenetic influences, and evaluating social functioning and quality of life in patients suffering from severe mental disorders. His contributions have been instrumental in improving the understanding of conditions such as schizophrenia, bipolar disorder, and neurodegenerative diseases, providing valuable insights for clinical interventions.

🏆 Recognized for Excellence in Neuroscience and Psychology

Through his commitment to scientific discovery, Joan Vicent has garnered recognition in the field of neuroscience and psychology. His contributions to neuropsychology and mental health research have positioned him as a promising figure in cognitive science. His work is widely acknowledged for its impact on the development of new therapeutic approaches and diagnostic techniques. With a strong academic and research background, he continues to be an influential voice in the study of cognitive impairment.

🌍 Impacting Lives Through Mental Health Research

Beyond academic achievements, Joan Vicent’s work has real-world implications, improving the quality of life for individuals facing cognitive challenges. His research contributes to developing more effective treatments, enhancing diagnostic accuracy, and fostering a better understanding of mental disorders. Through his role at INCLIVA and CIBERSAM, he actively collaborates with interdisciplinary teams, ensuring that his findings are translated into clinical practice, ultimately benefiting patients and healthcare professionals alike.

🚀 Paving the Way for Future Innovations in Neuropsychology

With a strong foundation in psychology, neuroscience, and medicine, Joan Vicent remains dedicated to pushing the boundaries of cognitive research. His ongoing studies aim to integrate cutting-edge techniques in neuroimaging, genetics, and artificial intelligence to refine the understanding of neurocognitive disorders. His ambition is to contribute to the development of personalized medicine, where treatments are tailored to an individual’s neurobiological and psychological profile, revolutionizing mental healthcare.

🔮 A Vision for a Healthier, Cognitively Resilient Future

Looking ahead, Joan Vicent Sánchez Ortí envisions a world where mental health is better understood, diagnosed, and treated with precision. His dedication to neuropsychology and cognitive research will continue to shape the future of mental healthcare, inspiring new generations of scientists and clinicians. As he advances in his career, his unwavering commitment to improving lives through research stands as a testament to his passion and perseverance in the field of neuroscience.

Publication

  • Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
    P Correa-Ghisays, V Balanzá-Martínez, G Selva-Vera, J Vila-Francés, …
    2017

 

  • Grip Strength, Neurocognition, and social functioning in people With Type-2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia
    M Aliño-Dies, JV Sanchez-Orti, P Correa-Ghisays, V Balanzá-Martinez, …
    2020

 

  • Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study
    P Correa-Ghisays, JV Sánchez-Ortí, R Ayesa-Arriola, E Setién-Suero, …
    2019

 

  • Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
    JV Sanchez‐Orti, V Balanzá‐Martinez, P Correa‐Ghisays, G Selva‐Vera, …
    2022

 

  • Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and …
    M Garés-Caballer, JV Sánchez-Ortí, P Correa-Ghisays, …
    2022

 

  • Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials
    C Ribera, JV Sánchez-Ortí, G Clarke, W Marx, S Mörkl, …
    2024

 

  • Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, G Selva-Vera, …
    2022

 

  • Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2023

 

  • MICEmi: A method to identify cognitive endophenotypes of mental illnesses
    P Correa-Ghisays, JV Sanchez-Orti, V Balanza-Martinez, I Fuentes-Dura, …
    2022

 

  • Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders
    JV Sanchez-Orti, P Correa-Ghisays, V Balanza-Martinez, G Selva-Vera, …
    2025

 

Conclusion 🎯

Joan Vicent Sánchez Ortí’s dedication to neuroscience and mental health research positions him as an influential figure in the field. His expertise bridges psychology, medicine, and genetics, offering innovative solutions for cognitive disorders. With a strong commitment to improving lives through research, his work has already made a meaningful impact and will continue to shape the future of mental healthcare, neuropsychology, and personalized medicine. As he advances in his career, his passion and contributions will undoubtedly lead to groundbreaking discoveries in cognitive science.

Sunita Pokhrel Bhattarai | Cognitive | Best Researcher Award

Posted on by Neuroscientists

Dr. Sunita Pokhrel Bhattarai | Cognitive | Best Researcher Award

Dr. Sunita Pokhrel, Bhattarai Ohio State University, United States.

Dr. Sunita Pokhrel Bhattarai, Ph.D., RN, is a distinguished nursing scholar and practitioner with a remarkable academic and professional journey. Her career began with an exceptional academic foundation in nursing, supported by prestigious scholarships. She transitioned seamlessly from clinical excellence in Nepal to advanced research and education in the global arena. Her doctoral research at the University of Rochester, focused on innovative methods for diagnosing acute heart failure, underscores her contributions to cardiovascular nursing. Beyond clinical practice, Sunita has excelled in academia, research coordination, and manuscript review, emphasizing her influence in the global nursing and healthcare community. Her accolades, including diversity and travel grants, reflect her dedication to excellence and equity in healthcare.

Profile

Scholar

🩺 Early Academic Pursuits: A Foundation of Excellence

Sunita Pokhrel Bhattarai, Ph.D., RN, began her academic journey with an unwavering commitment to healthcare and nursing education. From earning her Proficiency Certificate in Nursing on a full government scholarship in Nepal to completing her Bachelor’s in Nursing with a specialization in Community Health, Sunita demonstrated a dedication to academic excellence. Her early research on the knowledge and consequences of teenage marriage in Nepal set the stage for her future pursuits. This strong foundation was further reinforced through her Master’s studies in Emergency and Critical Care Nursing under the Erasmus Mundus Scholarship, where she explored advanced cardiac life support knowledge among critical care nurses.

💼 Professional Endeavors: Leadership in Nursing Practice and Education

Sunita’s professional trajectory reflects a remarkable blend of clinical expertise and academic leadership. She served as a Registered Nurse in Nepal’s premier institutions, including Shahid Gangalal National Heart Centre, where she specialized in cardiac care. Transitioning into academia, she became a Nursing Lecturer at Purbanchan University, imparting her knowledge to future nurses. These roles enriched her understanding of healthcare delivery and education, enabling her to contribute effectively to the global nursing community.

🔬 Contributions to Cardiovascular Research: Bridging Practice and Science

Driven by a passion for advancing cardiovascular care, Sunita’s research focuses on acute heart failure and innovative diagnostic approaches. Her doctoral research at the University of Rochester aimed to estimate left ventricular ejection fraction using ECG, a novel contribution to acute heart failure management. Her involvement in multidisciplinary projects, such as investigating the optimal timing for coronary angiography, highlights her ability to bridge clinical practice and scientific inquiry. Her research not only addresses critical clinical questions but also emphasizes the importance of evidence-based solutions in nursing.

🏆 Accolades and Recognition: Celebrating a Trailblazer

Sunita’s outstanding contributions have been recognized with numerous awards and grants. Notable honors include the Presidential Stronger as One Diversity Award from the University of Rochester and the Ireta Neumann Scholarship for International Nurses. Her achievements underscore her dedication to fostering diversity and excellence in nursing. Travel grants from esteemed organizations like the American Heart Association and the International Society for Computerized Electrocardiology further reflect her active participation in the global research community.

🌍 Impact and Influence: Advancing Global Health Equity

Sunita’s work extends beyond research and practice to address disparities in healthcare delivery. With a keen interest in self-care, implementation science, and healthcare discrepancies, she aims to enhance patient outcomes and equity in access to care. Her contributions as a research lead coordinator and manuscript reviewer illustrate her influence in shaping nursing science. Through mentorship and scholarly collaboration, she continues to inspire the next generation of healthcare professionals.

🧠 Legacy of Expertise: Pioneering Big Data and Applied Statistics

Sunita’s proficiency in big data analysis and applied statistics distinguishes her as a thought leader in nursing research. By leveraging these tools, she has contributed to clinical trials and comprehensive literature reviews that inform evidence-based practice. Her role as an abstract reviewer and researcher underscores her commitment to advancing knowledge in cardiovascular nursing and beyond.

🌟 Future Contributions: A Vision for Transformative Healthcare

With her multifaceted expertise and global perspective, Sunita is poised to drive innovation in healthcare. Her dedication to improving acute heart failure diagnostics, addressing healthcare disparities, and mentoring emerging scholars positions her as a transformative figure in nursing science. Her journey is a testament to the power of perseverance, scholarship, and a passion for improving lives.

📚 Publications

  • Delays in door-to-diuretic time and 1-year mortality among patients with heart failure
    Authors: DJ Dzikowicz, SP Bhattarai, J Ng, AL Zemanek, MG Carey
    Year: 2022

 

  • Signs and Symptoms Clusters Among Patients With Acute Heart Failure: A Correlational Study
    Authors: S Pokhrel Bhattarai, DJ Dzikowicz, MG Carey
    Year: 2023

 

  • Integrative review of electrocardiographic characteristics in patients with reduced, mildly reduced, and preserved heart failure
    Authors: SP Bhattarai, RC Block, Y Xue, DH Rodriguez, RG Tucker, MG Carey
    Year: 2024

 

  • Knowledge and practices on prevention of coronary artery diseases in Nepalese community: A cross-sectional from five different cities in Nepal
    Authors: SP Bhattarai, P Neupane
    Year: 2018

 

  • Estimating Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure
    Authors: SP Bhattarai, DJ Dzikowicz, Y Xue, R Block, RG Tucker, S Bhandari, …
    Year: 2024

 

  • Door-to-Diuretic Time is related to length of hospital stay independent of diuretic dose among acute decompensated heart failure patients
    Authors: DJ Dzikowicz, M Aktas, SP Bhattarai, L Chen, MG Carey
    Year: 2025

 

  • Estimating very low ejection fraction from the 12 Lead ECG among patients with acute heart failure
    Authors: SP Bhattarai, DJ Dzikowicz, Y Xue, R Block, RG Tucker, S Bhandari, …
    Year: 2025

 

  • Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure
    Authors: S Pokhrel Bhattarai, DJ Dzikowicz, MG Carey
    Year: 2025

 

  • Estimating ejection fraction from the 12 lead ECG in acute heart failure
    Authors: SB Pokhrel, DJ Dzikowicz, S Bhandari, VE Boulware, MG Carey
    Year: 2024

 

  • Interaction Between Door To Diuretic Time And Dosing As A Predictor Of Mortality And Readmission
    Authors: D Dzikowicz, SP Bhattarai, L Chen, MG Carey
    Year: 2024

 

Conclusion

Dr. Sunita Pokhrel Bhattarai’s journey illustrates the power of knowledge, resilience, and a commitment to improving healthcare. By integrating clinical expertise, innovative research, and global collaboration, she has advanced the field of cardiovascular nursing and inspired future generations. Her ongoing work promises to bridge gaps in healthcare delivery, enhance patient outcomes, and drive transformative change in nursing science. Sunita’s legacy is one of impact, innovation, and an enduring dedication to the betterment of global health.

Samira Jafari | Brain Mapping | Best Researcher Award

Posted on by Neuroscientists

Dr. Samira Jafari | Brain Mapping | Best Researcher Award

Dr Samira Jafari, Kerman university of medical sciences, Iran.

Dr. Samira Jafari, a distinguished Ph.D. in Biostatistics at Kerman University of Medical Sciences, is a leading researcher in biostatistics, machine learning methods, and meta-analysis. With 11 research projects and 11 journal publications in SCI and Scopus-indexed journals, she has made significant contributions to healthcare research, focusing on data-driven solutions. Her work in integrating machine learning with biostatistical models aims to enhance health data analysis, with the potential for improving disease prediction, public health policies, and medical practices.

Profile

Scholar

Early Academic Pursuits: The Foundation of Expertise 📚

Dr. Jafari’s academic journey began with a strong foundation in biostatistics, where she honed her analytical skills and developed a passion for understanding the intricacies of data. During her studies, she was captivated by the potential of machine learning to transform data analysis in healthcare, laying the groundwork for her future endeavors. Her early academic pursuits focused on mastering statistical models and computational techniques, which would become the bedrock of her later research.

Professional Endeavors: Shaping Research Landscape 🧑‍🔬

Since completing her Ph.D., Dr. Jafari has become a key figure in advancing biostatistics research, particularly through her exploration of machine learning applications. At Kerman University of Medical Sciences, she has led numerous research projects, with a total of 11 completed and ongoing studies. Her expertise has contributed to groundbreaking work in applying biostatistics and machine learning methods to analyze large-scale healthcare data. Dr. Jafari’s research provides essential insights that enhance the understanding of disease patterns and contribute to better health outcomes.

Contributions and Research Focus: Bridging Knowledge and Practice 🧠

Dr. Jafari’s research contributions are particularly notable in the integration of machine learning algorithms with biostatistics to improve health data interpretation. Her work includes innovative meta-analytic methods to synthesize complex data and uncover underlying patterns that inform healthcare practices. By combining machine learning with statistical models, she has been able to provide robust solutions for various medical and epidemiological studies. With 11 journal publications in top-tier journals like SCI and Scopus, her research has had a significant impact on advancing statistical methods in biostatistics.

Accolades and Recognition: Scholarly Achievements 🏆

Dr. Jafari’s scholarly achievements have not gone unnoticed. Her work has earned recognition through a citation index of 2, reflecting her contributions to the academic community. Despite the limited citations, her research is highly regarded for its innovative approach to statistical modeling and its potential applications in the field of biostatistics. She has made a lasting impression through her academic rigor, innovative methods, and dedication to enhancing the quality of healthcare research.

Impact and Influence: Leading the Way in Quantitative Healthcare Research 🌍

Dr. Jafari’s work in biostatistics and machine learning has influenced both academic research and practical applications in healthcare. Her innovative approaches to analyzing and interpreting health data have the potential to change how public health research is conducted, improving the accuracy and efficacy of healthcare models. The widespread application of her research is likely to influence future healthcare policy and contribute to the development of more precise, data-driven medical treatments.

Legacy and Future Contributions: A Path to Continued Innovation 🔮

Dr. Jafari’s research journey is far from over. With numerous ongoing projects, she is poised to continue contributing to the field of biostatistics, machine learning, and meta-analysis. As a dedicated researcher, her future work promises to explore new frontiers in data analysis, helping to bridge the gap between complex statistical methods and practical healthcare applications. Dr. Jafari’s contributions will undoubtedly have a lasting impact on the way we analyze medical data, shaping the future of healthcare and biostatistics for years to come.

📚 Publications

  • Title: The best drug supplement for obesity treatment: a systematic review and network meta-analysis
    Authors: N Salari, S Jafari, N Darvishi, E Valipour, M Mohammadi, K Mansouri, …
    Year: 2021

 

  • Title: Classifying patients with lumbar disc herniation and exploring the most effective risk factors for this disease
    Authors: S Jafari, T Dehesh, F Iranmanesh
    Year: 2019

 

  • Title: Diagnosis of borderline personality disorder based on Cyberball social exclusion task and resting-state fMRI: using machine learning approach as an auxiliary tool
    Authors: S Jafari, A Almasi, H Sharini, S Heydari, N Salari
    Year: 2023

 

  • Title: The best surgical treatment for cervical radiculopathy: a systematic review and network meta-analysis
    Authors: A Almasi, S Jafari, L Solouki, N Darvishi
    Year: 2023

 

  • Title: Radiomics-based machine learning for automated detection of Pneumothorax in CT scans
    Authors: H Alimiri Dehbaghi, K Khoshgard, H Sharini, S Jafari Khairabadi, …
    Year: 2024

 

  • Title: Diagnosis of traumatic liver injury on computed tomography using machine learning algorithms and radiomics features: The role of artificial intelligence for rapid diagnosis in …
    Authors: HA Dehbaghi, K Khoshgard, H Sharini, SJ Khairabadi
    Year: 2024

 

  • Title: A assessment of the effects of parental age on the development of autism in children: a systematic review and a meta-analysis
    Authors: T Dehesh, MA Mosleh-Shirazi, S Jafari, E Abolhadi, P Dehesh
    Year: 2024

 

Conclusion

Dr. Samira Jafari stands as a trailblazer in the field of biostatistics and machine learning, making invaluable contributions to healthcare research. Through her innovative integration of machine learning with biostatistical models, she has advanced our understanding of complex health data, paving the way for more accurate predictions and improved healthcare outcomes. With her extensive research experience and a clear commitment to bridging data analysis with real-world medical applications, Dr. Jafari is set to leave a lasting legacy in both academic and healthcare sectors.

Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Posted on by Neuroscientists

Mr. Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist Award 

Mr. Md Shimul Bhuia , BioLuster Research Center Limited,  Bangladesh.

An accomplished pharmacist and researcher with expertise in pharmaceutical sciences, molecular docking, and drug development. Awarded the prestigious National Science and Technology Fellowship (NST) in 2023 for contributions to science. Extensive experience includes an internship at Beximco Pharmaceuticals, part-time pharmacy practice, and a full-time role as Deputy Director at BioLuster Research Center. Proficient in advanced software for computational drug design and well-versed in research methodologies. Fluent in Bangla and highly proficient in English, with strong technical and analytical skills.

 

profile

scholor

🎓 Education and Academic Achievements

Master of Pharmacy (M. Pharm.) Department of Pharmacy, Life Science Faculty. Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Bangladesh Session: 2020–2021 Course Duration: 1.5 years (3 Semesters)Passing Year: 2022 CGPA: 3.74 (out of 4.00). Bachelor of Pharmacy (B. Pharm.) Department of Pharmacy, Life Science Faculty .Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, BangladeshSession: 2016–2017  Course Duration: 4 years Hon’s (8 Semesters) Passing Year: 2020 CGPA: 3.45 (out of 4.00)  Higher Secondary Certificate (H.S.C.)  Shahid Bul Bul Govt. College, Pabna Board: Rajshahi Group: Science Passing Year: 2016 GPA: 5.00 (out of 5.00) Secondary School Certificate (S.S.C.) Kamal Pur T.M. High School, Ishwardi, Pabna Board: Rajshahi  Group: Science Passing Year: 2013 GPA: 5.00 (out of 5.00).

🎯 Research Interests

Neurology/Neurodegenerative Diseases , Immunology ,  Cancer Therapy , Toxicology , Molecular Docking , Drug Design and Development via Computational Studies ,Pharmacological Investigation through Preclinical Test Systems , Inflammatory Diseases , Bioinformatics , Anti-cancer Agents

🏆 Honours and Awards

National Science and Technology Fellowship (NST), 2023. Awarded by the Ministry of Science and Technology, Government of Bangladesh

💼 Work Experiences

InternshipBeximco Pharmaceutical Ltd., Squibb Road, Tongi, Bangladesh Duration: November 13, 2022, to November 23, 2022. Pharmacist Worked as a pharmacist at Gafur Chikitsaloi (local pharmacy shop)Employee Status: Part-Researcher Deputy Director, BioLuster Research Center, Gopalganj 8100, Dhaka, Bangladesh Employee Status: Full-time (January 01 – Present)

📚 Publications

 

 Conclusion

With a strong foundation in both clinical practice and academic leadership, Leila Sadati’s career reflects a commitment to advancing healthcare education and patient safety standards. Her contributions in research, curriculum development, and operational management have shaped future medical professionals and enhanced patient care practices. As she continues to innovate and educate, her work remains instrumental in raising the standards of medical and surgical education in Iran and beyond.

 

 

Mohammad Satarzadeh | Cognitive impairments | Best Researcher Award

Posted on by Neuroscientists

Mr. Mohammad Satarzadeh | Cognitive Impairments | Best Researcher Award

Mr. Mohammad Satarzadeh Hormozgan medical science university Iran

Mohammad Satarzadeh, born in March 1999 in Arak, is a dedicated nursing graduate with a passion for medicine and healthcare. He completed his Bachelor’s in Nursing from Hormozgan University of Medical Sciences, scoring 16.60 out of 20, and previously attended Payame Noor University for Cellular and Molecular Biology. Fluent in Persian and conversational in both French and Arabic, he is also working towards improving his English for IELTS.

 

profile

scopus

EDUCATION 🎓

Bachelor of Cellular and Molecular BiologyPayame Noor University, Arak (2018–2019)After completing two semesters, I decided to pivot my focus and applied to the University of Medical Sciences.Bachelor of NursingHormozgan University of Medical Sciences, Bandar Abbas (2019–2023)Total Score: 16.60/20

 

EXPERIENCE 📝

I have contributed to several research articles in reputable journals, showcasing my dedication to scientific inquiry:Shigella Antibiotic Resistance in Pediatric Shigellosis Infection: A retrospective study in Hormozgan (Corresponding author, ISI indexed)New Dimension of Epilepsy Complications: A systematic review of visual and retinal disorders (Corresponding author, under review, ISI indexed in BMC Ophthalmology)Maternal Smoking during Pregnancy and Its Effects on Neural Tube Defects: A holistic systematic review (Accepted, PubMed indexed)Additionally, I have four articles submitted for publication and five more in preparation for submission before January 2024.

 

RESEARCH PROJECTS 🔬

Effect of Personality Types on Heart Disease Prognosis: A systematic review.Incidence of Infections in Children with Leukemia: Conducted at Bandar Abbas Children’s Hospital (2020-2023).Neonatal Neutropenia and Leukopenia: Study in infants admitted to Shariati Bandar Abbas Hospital (2021-2023).Prevalence of Hepatitis B, C, and D: In thalassemia patients referred to Aburihan Center, Bandar Abbas.Burns from Alkaline Substance Ingestion: Cases studied at Bandar Abbas Children’s Hospital (2019-2023)

 

REVIEWER EXPERIENCE 🏅

Reviewer for a cohort article published in the Italian Pediatric JournalReviewer for the Tobacco Congress held at Hormozgan Medical Sciences University (March 2022).Active reviewer for Hematology, Immunology, and Pediatric departments at Hormozgan Medical Sciences University (4 recommendation letters available)

 

📚 Publications

  • Title: Dental Pulp Stem Cells Regenerate Neural Tissue in Degenerative Disorders and Stroke Rehabilitation: A Scope Systematic Review
    Authors: Rahnama Sisakht, A., Tavasouli, Z., Negahi, A., Hosseini, S.A., Satarzadeh, M.
    Year: 2024
    Journal: Heliyon, Volume 10, Issue 15, e35080

 

  • Title: Mothers’ Health-Seeking Behaviors and Ignorance of Children’s Fever: A Cross-Sectional Study
    Authors: Tariverdi, M., Sakhtemanpour Bolouki, S., Tamaddondar, M., Rahmati, M.B., Mohammadian, M.
    Year: 2024
    Journal: Archives of Pediatric Infectious Diseases, Volume 12, Issue 3, e142885

 

  • Title: Maternal Smoking during Pregnancy and its Effects on Neural Tube Defects
    Authors: Elahi, Z., Hassanzadeh, F., Satarzadeh, M.
    Year: 2024
    Journal: Iranian Journal of Child Neurology, Volume 18, Issue 3, Pages 103–115

 

Conclusion

Mohammad’s academic background, research contributions, and determination to overcome challenges in the Iranian academic environment position him as a strong candidate for postgraduate studies. His pursuit of international education aims to broaden his expertise, offering him the opportunity to expand his research capabilities and contribute to global medical knowledge. His drive, research skills, and experience in the medical field align well with his career aspirations, making him a promising candidate for further academic and professional growth in healthcare.